Saturday , September 22 2018
Home / Steve Freed, R.PH., CDE

Steve Freed, R.PH., CDE

Steve Freed, R.PH., CDE
(Publisher Diabetes In Control) Stephen Freed, a registered pharmacist and diabetes educator, is the founder and publisher of Diabetes In Control. He is dedicated to advancing diabetes care for patients, physicians, pharmacists, and nurses. Steve has worked with many physicians helping them manage their diabetes patients. He has been president of the Chicago Chapter of the American Association of Diabetes Educators, is a certified pump trainer, and has developed and presented CE/CME programs for AADE.

Dace Trence 2018 Complete Interview

Dace L. Trence, MD, FACE received her MD degree from the University of Minnesota Medical School.  She completed an internal medicine residency through Northwestern Hospital in Minneapolis and, subsequently, returned to the University of Minnesota for Endocrine Fellowship.  Dr. Trence started practice with Group Health, Inc, in Minnesota, becoming Chief of Endocrinology, initiating several programs, including a Lipids Clinic, Diabetes Foot Care Clinic, and a Diabetes and Pregnancy Clinic.  After moving to Seattle to practice at Group Health of Puget Sound, becoming Chief of Endocrinology, then Chief of Medical Subspecialties, she then joined the faculty at the University of Washington. Currently she is a Professor in the Department of Medicine,  Director of the Diabetes Care Center and Director of the Endocrine Fellowship Program at the University of Washington.

Read More »

Grenye O’Malley 2018 Complete Interview

Grenye O’Malley, MD, graduated from NYU School of Medicine. She then completed residency in Internal Medicine at the Icahn School of Medicine at Mount Sinai. During residency, she developed an interest in diabetes management and was involved in research on glucose sensor use in patients with type 1 diabetes during pregnancy. She is now a graduating fellow at Icahn School of Medicine at Mount Sinai where she will be an Assistant Professor later this year. She is participating in multiple large clinical trials involving type 1 diabetes technologies, including a closed-loop artificial pancreas study, a first of its kind assessment of decision support algorithms for patients using multiple daily injections, and a study of continuous glucose monitoring in the elderly.

Read More »